Unlock stock picks and a broker-level newsfeed that powers Wall Street.
IOB - Delayed Quote EUR

Clariane SE (0OPS.IL)

Compare
3.6670
-0.2030
(-5.25%)
At close: April 4 at 5:14:05 PM GMT+1
Loading Chart for 0OPS.IL
  • Previous Close 3.8700
  • Open 3.9420
  • Bid 3.5760 x --
  • Ask 3.7580 x --
  • Day's Range 3.6680 - 3.9420
  • 52 Week Range 1.4940 - 5.4400
  • Volume 26,912
  • Avg. Volume 143,836
  • Market Cap (intraday) 437.873M
  • Beta (5Y Monthly) 1.16
  • PE Ratio (TTM) 21.57
  • EPS (TTM) 0.1700
  • Earnings Date Feb 24, 2025
  • Forward Dividend & Yield 0.25 (4.94%)
  • Ex-Dividend Date Jun 21, 2023
  • 1y Target Est --

Clariane SE provides a range of medical and non-medical care and support services for the elderly and people with short or longer-term health issues. The company operates long-term care nursing homes, specialized clinics, and assisted living and shared housing facilities for seniors, as well as offers home care, support, and hospitalization services. It operates approximately health care facilities and networks in France, Germany, Italy, Spain, the Netherlands, Belgium, and the United Kingdom. The company was formerly known as Korian and changed its name to Clariane SE in June 2023. Clariane SE was founded in 2001 and is headquartered in Paris, France.

www.clariane.com

67,000

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 0OPS.IL

View More

Performance Overview: 0OPS.IL

Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is CAC 40 (^FCHI) .

YTD Return

0OPS.IL
77.24%
CAC 40 (^FCHI)
1.43%

1-Year Return

0OPS.IL
107.53%
CAC 40 (^FCHI)
10.75%

3-Year Return

0OPS.IL
81.41%
CAC 40 (^FCHI)
8.08%

5-Year Return

0OPS.IL
85.80%
CAC 40 (^FCHI)
75.11%

Compare To: 0OPS.IL

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 0OPS.IL

View More

Valuation Measures

Annual
As of 4/4/2025
  • Market Cap

    1.32B

  • Enterprise Value

    8.78B

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.16

  • Price/Book (mrq)

    0.35

  • Enterprise Value/Revenue

    1.66

  • Enterprise Value/EBITDA

    8.29

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.22%

  • Return on Assets (ttm)

    1.21%

  • Return on Equity (ttm)

    0.98%

  • Revenue (ttm)

    4.74B

  • Net Income Avi to Common (ttm)

    28.04M

  • Diluted EPS (ttm)

    0.1700

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    411.26M

  • Total Debt/Equity (mrq)

    215.79%

  • Levered Free Cash Flow (ttm)

    84.69M

Research Analysis: 0OPS.IL

View More

Company Insights: 0OPS.IL

Research Reports: 0OPS.IL

View More

People Also Watch